UBS Raises The Procter & Gamble (PG) Price Target to $190
Key Points
- UBS reaffirmed its Buy rating on The Procter & Gamble Company on October 23, 2026, pushing its price target up from $172.00 to $190.00.
- UBS's $190 price target implies 17.97% upside from The Procter & Gamble Company's ($PG) current $161.06 share price.
- The consumer goods maker brought in $87.92 billion in trailing twelve month revenue with a net profit margin of 18.2% and an earnings per share of $6.64.
- Three company insiders sold shares on October 5, 2026, while Wall Street overall holds a consensus buy recommendation on the stock.
Get The Procter & Gamble Company text alerts
We text you when insiders, Congress, analysts or big funds move on $PG.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated The Procter & Gamble Company alert may contain errors. Disclosures
On October 23, 2026, UBS kept its Buy rating on The Procter & Gamble Company [NYSE: PG] while boosting its price target from $172.00 to $190.00. The research note arrived as part of a broader round of target adjustments from major financial firms covering the consumer goods giant. UBS joins several peers in expressing an optimistic view on the Cincinnati-based manufacturer.
UBS vs. the S&P 500
Hypothetical returns from UBS's disclosed trades, not real profit or advice. How we model this.
UBS's Call on Procter & Gamble
In its research note issued on October 23, 2026, UBS maintained its Buy rating and raised its target to $190.00 from $172.00. The revised target matches the high end of analyst estimates tracked for the company. The call stands out among recent Wall Street updates for carrying one of the higher targets on the table.
The Procter & Gamble Company Stock Up 2.7%
The stock recently traded around $161.06 as of October 23, 2026, sitting close to its event closing price of $161.02 on that same day. Shares trade comfortably above both their 50-day moving average of $148.03 and their 200-day moving average of $148.40. The current price sits about 3.7% below the 52-week high of $167.25.
$PG price target
The Procter & Gamble Company daily closes and this analyst's $190 target. Not advice.
Recent Earnings
The company posted trailing twelve month revenue of $87.92 billion alongside year-over-year revenue growth of 4.0%. Profitability metrics show strong returns, featuring a net profit margin of 18.2% and a return on equity of 29.6%. Earnings per share over the trailing twelve month period reached $6.64, while the price-to-earnings ratio stands at 24.94. Its next earnings report is scheduled for January 21, 2027.
Dividend
The company pays an annual dividend rate of $4.35 per share, yielding 2.63%. The payout ratio sits at 64.3%, indicating that a moderate share of earnings goes toward shareholder distributions.
Insider Buying and Selling at The Procter & Gamble Company
Company insiders executed sales on October 5, 2026. Chief Financial Officer Andre Schulten disposed of 3,914 shares at $145.34 apiece for a total value of $568,861. Officer Susan Street Whaley sold 2,369 shares at the same price for a total of $344,310. Officer Paul Gama also parted with 2,225 shares at $145.34 per share, totaling $323,382.
Analysts Set New Price Targets
Wall Street currently tracks the stock with a consensus buy recommendation and a mean price target of $168.87 across 23 analyst opinions. On October 23, 2026, Freedom Broker upgraded the stock to a Buy rating with a $176.00 price target. On the same date, Citigroup maintained its Buy rating and moved its target from $180.00 to $187.00, BNP Paribas kept an Outperform rating while lifting its target to $189.00 from $177.00, and JP Morgan kept an Overweight rating with a target raised to $180.00 from $162.00.
About The Procter & Gamble Company
Headquartered in Cincinnati, Ohio, The Procter & Gamble Company makes everyday household and personal care items sold around the world. Its operations span five main areas covering beauty products, grooming tools, health care items, fabric and home care solutions, and baby, feminine, and family care supplies. The firm's massive global footprint makes its financial health a key bellwether for consumer spending habits.
Bottom Line
Investors will watch for the company's next earnings update on January 21, 2027, to see if revenue growth continues at its current pace. Monitoring broader analyst revisions can help determine if the rest of Wall Street follows UBS in lifting price targets.
Source: UBS's rating change on $PG (Oct 23, 2026). Written by software, not financial advice. How we make alerts